Annual Total Assets
$341.86 M
+$270.71 M+380.52%
31 December 2023
Summary:
Spyre Therapeutics annual total assets is currently $341.86 million, with the most recent change of +$270.71 million (+380.52%) on 31 December 2023. During the last 3 years, it has risen by +$231.93 million (+210.99%). SYRE annual total assets is now at all-time high.SYRE Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$421.09 M
-$14.98 M-3.43%
30 September 2024
Summary:
Spyre Therapeutics quarterly total assets is currently $421.09 million, with the most recent change of -$14.98 million (-3.43%) on 30 September 2024. Over the past year, it has increased by +$79.23 million (+23.18%). SYRE quarterly total assets is now -13.64% below its all-time high of $487.60 million, reached on 31 March 2024.SYRE Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +23.2% |
| 3 y3 years | +211.0% | +283.1% |
| 5 y5 years | +311.0% | +406.2% |
SYRE Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +380.5% | -13.6% | +702.8% |
| 5 y | 5 years | at high | +380.5% | -13.6% | +702.8% |
| alltime | all time | at high | >+9999.0% | -13.6% | >+9999.0% |
Spyre Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $421.09 M(-3.4%) |
| June 2024 | - | $436.07 M(-10.6%) |
| Mar 2024 | - | $487.60 M(+42.6%) |
| Dec 2023 | $341.86 M(+380.5%) | $341.86 M(+64.9%) |
| Sept 2023 | - | $207.26 M(-14.9%) |
| June 2023 | - | $243.53 M(+364.3%) |
| Mar 2023 | - | $52.45 M(-26.3%) |
| Dec 2022 | $71.14 M(-35.3%) | - |
| Dec 2022 | - | $71.14 M(-22.3%) |
| Sept 2022 | - | $91.57 M(-14.2%) |
| June 2022 | - | $106.71 M(+28.3%) |
| Mar 2022 | - | $83.17 M(-24.3%) |
| Dec 2021 | $109.93 M(-32.0%) | $109.93 M(-14.8%) |
| Sept 2021 | - | $129.06 M(-12.2%) |
| June 2021 | - | $146.98 M(-10.2%) |
| Mar 2021 | - | $163.61 M(+1.2%) |
| Dec 2020 | $161.62 M(+94.3%) | $161.62 M(+3.8%) |
| Sept 2020 | - | $155.63 M(-10.0%) |
| June 2020 | - | $172.91 M(+166.9%) |
| Mar 2020 | - | $64.78 M(-22.1%) |
| Dec 2019 | $83.18 M | $83.18 M(-16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $100.10 M(-14.8%) |
| June 2019 | - | $117.49 M(-8.6%) |
| Mar 2019 | - | $128.52 M(+65.3%) |
| Dec 2018 | $77.74 M(+38.6%) | $77.74 M(+9.1%) |
| Sept 2018 | - | $71.28 M(-10.6%) |
| June 2018 | - | $79.71 M(+60.1%) |
| Mar 2018 | - | $49.79 M(-11.2%) |
| Dec 2017 | $56.08 M(-16.4%) | $56.08 M(-7.3%) |
| Sept 2017 | - | $60.50 M(-9.9%) |
| June 2017 | - | $67.14 M(+9.6%) |
| Mar 2017 | - | $61.27 M(-8.6%) |
| Dec 2016 | $67.06 M(+73.5%) | $67.06 M(-6.9%) |
| Sept 2016 | - | $72.06 M(-6.8%) |
| June 2016 | - | $77.30 M(+117.5%) |
| Mar 2016 | - | $35.54 M(-8.0%) |
| Dec 2015 | $38.65 M(+1219.2%) | $38.65 M(-8.2%) |
| Sept 2015 | - | $42.10 M(-7.8%) |
| June 2015 | - | $45.64 M(+2.9%) |
| Mar 2015 | - | $44.35 M(+1413.7%) |
| Dec 2014 | $2.93 M(-36.3%) | $2.93 M |
| Dec 2013 | $4.60 M | - |
FAQ
- What is Spyre Therapeutics annual total assets?
- What is the all time high annual total assets for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly total assets year-on-year change?
What is Spyre Therapeutics annual total assets?
The current annual total assets of SYRE is $341.86 M
What is the all time high annual total assets for Spyre Therapeutics?
Spyre Therapeutics all-time high annual total assets is $341.86 M
What is Spyre Therapeutics quarterly total assets?
The current quarterly total assets of SYRE is $421.09 M
What is the all time high quarterly total assets for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly total assets is $487.60 M
What is Spyre Therapeutics quarterly total assets year-on-year change?
Over the past year, SYRE quarterly total assets has changed by +$79.23 M (+23.18%)